Navigation Links
The MPN Research Foundation and LLS partner
Date:2/14/2013

Chicago, IL, and White Plains, NY, USA Feb. 14, 2013 - In 2012, The Myeloproliferative Neoplasm (MPN) Research Foundation and The Leukemia & Lymphoma Society (LLS) jointly issued the MF Challenge Grant , seeking innovative approaches to reversing fibrosis in patients with myelofibrosis (MF). The challenge resulted in many high quality applications, therefore, the two organizations are continuing with a second round of applications.

Applicants for this concept grant program will have until April 1, 2013 to submit their proposal for funding of up to $100,000 per grant. The grant review will take place in May 2013.

"Concept grants" are used to identify innovative and novel approaches to an issue. Since the objective is to identify and fund new approaches to fibrosis, applicants are not required to have preliminary data. Success for a grant is defined as proving an idea is worth pursuing further.

Fibrosis is the formation of excessive fibrous connective tissue in place of healthy tissue. The disease myelofibrosis (one of the myeloproliferative neoplasms) is characterized by fibrosis in the bone marrow. Though some patients may live for many years with relatively mild symptoms, others have a much bleaker outlook. The only potential cure for MF is a stem cell transplant, which is an option for only a small number of MF patients. The disease in a small proportion of MF patients can transform to acute myeloid leukemia (AML), a highly lethal type of blood and bone marrow cancer that progresses rapidly. MPN Research Foundation President Barbara Van Husen says this grant program has already stimulated scientific interest in myelofibrosis.

"It is our hope that by bringing a broad range of experts to focus on myelofibrosis we can capitalize on important research in other areas of fibrosis and cancer research for the benefit of MPN patients and many others," Van Husen said.

"LLS aggressively and proactively searches for opportunities to improve the lives of patients by funding areas of research addressing critical unmet medical needs. The lack of a cure for the majority of patients with myelofibrosis presents a challenge that we must address, said Richard C. Winneker, Ph.D., LLS senior vice president, research. "LLS looks forward to our continued partnership with the MPN Research Foundation for a second year to meet the challenge for patients with myelofibrosis."


'/>"/>

Contact: Andrea Greif
andrea.greif@lls.org
914-821-8958
The Leukemia & Lymphoma Society
Source:Eurekalert

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
Breaking Medicine Technology: